Market Place
Sourcing Support
Lyell Immunopharma Reports Business & Financial Results for Q3 2024
07 Nov 2024 //
GLOBENEWSWIRE
Lyell Presents Phase 1-2 Data for IMPT-314 in B-cell Lymphoma
05 Nov 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Completes Acquisition of ImmPACT Bio
31 Oct 2024 //
GLOBENEWSWIRE
Lyell Immunopharma To Acquire ImmPACT Bio For CAR T-cell
24 Oct 2024 //
GLOBENEWSWIRE
Lyell Announces Abstracts For SITC Annual Meeting
04 Oct 2024 //
GLOBENEWSWIRE
Lyell Immunopharma to Join Goldman Sachs Cell Therapy Day
24 Sep 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Announces Participation in September Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Q2 2024 Results And Business Highlights
07 Aug 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Dose-dependent Activity From Phase 1 Trial
26 Jun 2024 //
GLOBENEWSWIRE
CAR-T death drives Lyell to take 2-track approach to dose escalation
26 Jun 2024 //
FIERCE BIOTECH
Lyell To Participate In Goldman Sachs Healthcare Conference
03 Jun 2024 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
06 May 2024 //
GLOBENEWSWIRE
Lyell Reports Q1 2024 Highlights, Financial Results
06 May 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation
05 Mar 2024 //
GLOBENEWSWIRE
Lyell Reports Financial Results for the Fourth Quarter and Full Year 2023
28 Feb 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Announces Participation in March Investor Conferences
26 Feb 2024 //
GLOBENEWSWIRE
Lyell to Participate in 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845
09 Nov 2023 //
GLOBENEWSWIRE
Lyell loses 25% of staff, CMO to conserve cash post-GSK collab
08 Nov 2023 //
FIERCE BIOTECH
Lyell Reports Business Highlights & Financial Results for the Third Quarter 2023
07 Nov 2023 //
GLOBENEWSWIRE
Lyell Presentations at SITC Highlight New Nonclinical Data on Product Candidates
31 Oct 2023 //
GLOBENEWSWIRE
Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation
27 Sep 2023 //
GLOBENEWSWIRE
Cellares & Lyell to Evaluate Manufacturing of Lyell`s CAR T-Cell Therapy
11 Sep 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in Upcoming Investor Conferences
31 Aug 2023 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Financial Results for the Second Quarter 2023
08 Aug 2023 //
GLOBENEWSWIRE
Lynn Seely brings ex-Myovant colleague to Lyell`s C-suite; Nkarta, Zai Lab name new CFOs
07 Jul 2023 //
ENDPTS
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
05 Jul 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in Goldman Sachs Global Healthcare Conference
07 Jun 2023 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Business Highlights & FYR for the 1Q 2023
04 May 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
02 May 2023 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Financial Results for Q4 and Full Year 2022
28 Feb 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Conference
03 Jan 2023 //
GLOBENEWSWIRE
Lyell Immunopharma Appoints Lynn Seely, MD as President and CEO
15 Dec 2022 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in BofA Securities Biotech Conference
01 Dec 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Recent Business Highlights and 3Q FYR
08 Nov 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline
07 Nov 2022 //
GLOBENEWSWIRE
GSK axes Lyell cell therapy, passes programs to Adaptimmune
26 Oct 2022 //
FIERCEBIOTECH
Lyell Immunopharma Announces FDA Clearance of its IND for LYL845, a TIL Product
06 Oct 2022 //
GLOBENEWSWIRE
Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell
05 Oct 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as CLO
28 Sep 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Presents First in Human Trial Design of LYL797 at ESMO 2022
10 Sep 2022 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in Morgan Stanley Global Healthcare Conference
30 Aug 2022 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in Goldman Sachs Global Healthcare Conference
07 Jun 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Reports First Quarter Financial Results
10 May 2022 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
04 May 2022 //
GLOBENEWSWIRE
Lyell Immunopharma to Present Preclinical Data for 2 Product Candidates at ASGCT
02 May 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Fourth Quarter and Full Year 2021 Financial Results
29 Mar 2022 //
GLOBENEWSWIRE
Lyell Immunopharma says Upcoming Presentation on LYL797 at AACR
08 Mar 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Appoints Gary Lee, Ph.D. as Chief Scientific Officer
31 Jan 2022 //
GLOBENEWSWIRE
FDA Clears Lyell`s IND for LYL132 for Solid Tumors in Collaboration with GSK
24 Jan 2022 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in J.P. Morgan Healthcare Conference
04 Jan 2022 //
GLOBENEWSWIRE
Lyell Immunopharma Announces FDA Clearance of its IND for LYL797
17 Dec 2021 //
GLOBENEWSWIRE
Lyell Immunopharma Announces FDA Clearance of its IND for LYL797
16 Dec 2021 //
GLOBENEWSWIRE
Psyence Group Functional Mushroom Brand “GOODMIND™” Commences
02 Dec 2021 //
GLOBENEWSWIRE
Lyell Reports Q3 2021 Financial Results and Business Highlights
12 Nov 2021 //
GLOBENEWSWIRE
Another four IPOs complete busy week as biotech raise continues to match 2020`s
18 Jun 2021 //
ENDPTS
Lyell Immunopharma Announces Completion of LyFE Manufacturing Center
23 Mar 2021 //
PRNEWSWIRE
Sarah Cannon & Lyell Immunopharma Announce Collaboration to Advance Development
26 Aug 2020 //
BUSINESSWIRE
GSK taps Lyell Immunopharma to take cell therapy to the next level
09 Oct 2019 //
FIERCE BIOETCH
